|
SCAND2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.21189946966638E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.60347299274599E-13 |
| Normal-vs-Stage2 |
4.144200E-03 |
| Normal-vs-Stage3 |
3.175300E-03 |
| Normal-vs-Stage4 |
3.005200E-01 |
| Stage1-vs-Stage2 |
4.030600E-01 |
| Stage1-vs-Stage3 |
3.165000E-03 |
| Stage1-vs-Stage4 |
8.09640000000167E-05 |
| Stage2-vs-Stage3 |
2.715600E-01 |
| Stage2-vs-Stage4 |
4.502500E-02 |
| Stage3-vs-Stage4 |
1.696360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.46410003512665E-09 |
| Normal-vs-AfricanAmerican |
3.755500E-04 |
| Normal-vs-Asian |
5.334300E-02 |
| Caucasian-vs-AfricanAmerican |
2.009400E-01 |
| Caucasian-vs-Asian |
4.039800E-01 |
| AfricanAmerican-vs-Asian |
8.571600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87404999999474E-05 |
| Normal-vs-Female |
2.31492602864591E-12 |
| Male-vs-Female |
1.044930E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.596600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.08419956240868E-10 |
| Normal-vs-Age(61-80Yrs) |
1.56787999999741E-05 |
| Normal-vs-Age(81-100Yrs) |
4.697400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.288160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.778000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.513370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.272300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.609200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.509790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.58498999999201E-05 |
| Normal-vs-Grade 2 |
2.30360175379474E-12 |
| Normal-vs-Grade 3 |
2.76340000004982E-06 |
| Normal-vs-Grade 4 |
3.821000E-01 |
| Grade 1-vs-Grade 2 |
4.359600E-03 |
| Grade 1-vs-Grade 3 |
2.2095999999916E-05 |
| Grade 1-vs-Grade 4 |
1.39889988481912E-10 |
| Grade 2-vs-Grade 3 |
6.296300E-03 |
| Grade 2-vs-Grade 4 |
2.33679964267708E-10 |
| Grade 3-vs-Grade 4 |
2.14779999999637E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
4.336400E-01 |
| ccA subtype-vs-ccB subtype |
1.01030295240889E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.17349965487324E-10 |
| Normal-vs-N1 |
5.507200E-01 |
| N0-vs-N1 |
1.678000E-02 |
|
|
